Hong Kong Orders GSK Pediatric Antibiotic Withdrawn From Market
This article was originally published in PharmAsia News
Executive Summary
Hong Kong health authorities ordered GlaxoSmithKline's Augmentin (amoxillin) pediatric antibiotic pulled from the market after hospitals found a plastics chemical in samples